NCT03431974View on ClinicalTrials.gov

Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

January 11, 2021

Study Completion Date

January 11, 2021

Conditions
Psoriasis
Interventions
DRUG

LD-Aminopterin oral capsule

anti-folate treatment

DRUG

Placebo oral capsule

Microcrystalline filled capsule to mimic capsule containing aminopterin tablets

Trial Locations (3)

85258

Spectrum Dermatology, Scottsdale

98101

Dermatology Associates of Seattle, Seattle

99202

Premier Clinical Research, Spokane

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Syntrix Biosystems, Inc.

INDUSTRY

NCT03431974 - Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis | Biotech Hunter | Biotech Hunter